Vlacho, B, Simarro, FL, Mata-Cases, M, Miravet, S, Escribano-Serrano, J, Asensio, D, Cortes, X, Franch-Nadal, J. Adherence to antidiabetic treatment among patients managed in primary care centres in Spain: the INTENSE study. Primary Care Diabetes. 2022; 16(6)DOI:10.1016/j.pcd.2022.10.004. PMID:36335018. IF:2.900(Q2/5D).

Puig-Jove, C, Julve, J, Castelblanco, E, Julian, MT, Amigo, N, Andersen, HU, Ahluwalia, TS, Rossing, P, Mauricio, D, Jensen, MT, Alonso, N. The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus. Cardiovascular Diabetology. 2022; 21(1)DOI:10.1186/s12933-022-01652-z. PMID:36434633. IF:9.300(Q1/1D).

Das Pradhan, A, Glynn, RJ, Fruchart, JC, MacFadyen, JG, Zaharris, ES, Everett, BM, Campbell, SE, Oshima, R, Amarenco, P, Blom, DJ, Brinton, EA, Eckel, RH, Elam, MB, Felicio, JS, Ginsberg, HN, Goudev, A, Ishibashi, S, Joseph, J, Kodama, T, Koenig, W, Leiter, LA, Lorenzatti, AJ, Mankovsky, B, Marx, N, Nordestgaard, BG, Pall, D, Ray, KK, Santos, RD, Soran, H, Susekov, A, Tendera, M, Yokote, K, Paynter, NP, Buring, JE, Libby, P, Ridker, PM, PEREZ PEREZ, ANTONIO, Prominent Investigators. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. NEW ENGLAND JOURNAL OF MEDICINE. 2022; 387(21)DOI:10.1056/NEJMoa2210645. PMID:36342113. IF:158.500(Q1/1D).

Castelblanco, E, Granado-Casas, M, Hernandez, M, Pinyol, M, Correig, E, Julve, J, Rojo-Lopez, MI, Alonso, N, Avogaro, A, Ortega, E, Mauricio, D. Diabetic retinopathy predicts cardiovascular disease independently of subclinical atherosclerosis in individuals with type 2 diabetes: A prospective cohort study. Frontiers in Cardiovascular Medicine. 2022; 9DOI:10.3389/fcvm.2022.945421. PMID:36407461. IF:3.600(Q2/5D).

Manzini, E, Vlacho, B, Franch-Nadal, J, Escudero, J, Genova, A, Reixach, E, Andres, E, Pizarro, I, Portero, JL, Mauricio, D, Perera-Lluna, A. Longitudinal deep learning clustering of Type 2 Diabetes Mellitus trajectories using routinely collected health records. JOURNAL OF BIOMEDICAL INFORMATICS. 2022; 135DOI:10.1016/j.jbi.2022.104218. PMID:36216232. IF:4.500(Q2/4D).

Canyelles, M, Perez, A, Junza, A, Minambres, I, Yanes, O, Sarda, H, Rotllan, N, Julve, J, Sanchez-Quesada, JL, Tondo, M, Escola-Gil, JC, Blanco-Vaca, F. Divergent Effects of Glycemic Control and Bariatric Surgery on Circulating Concentrations of TMAO in Newly Diagnosed T2D Patients and Morbidly Obese. Diagnostics. 2022; 12(11)DOI:10.3390/diagnostics12112783. PMID:36428843. IF:3.600(Q2/4D).

Gargallo-Fernandez, M, Escalada-San Martin, J, Chico-Ballesteros, A, Lecumberri-Pascual, E, Tejera-Perez, C, Fernandez-Garcia, JC, Rozas-Moreno, P, Marco-Martinez, A, Gomez-Peralta, F, Lopez-Fernandez, J. Executive summary of the consensus statement of: Clinical recommendations for sport practice in people with diabetes (RECORD Guide). Update 2021. Diabetes Mellitus Area of the Spanish Society of Endocrinology and Nutrition (SEEN). Endocrinologia Diabetes y Nutricion. 2022; 69(9)DOI:10.1016/j.endinu.2021.06.005. PMID:34489216. IF:1.900(Q4/9D).

Bundo, M, Vlacho, B, Llussa, J, Puig-Treserra, R, Mata-Cases, M, Cos, X, Jude, EB, Franch-Nadal, J, Mauricio, D. Prevalence and risk factors of diabetic foot disease among the people with type 2 diabetes using real-world practice data from Catalonia during 2018. Frontiers in Endocrinology. 2022; 13DOI:10.3389/fendo.2022.1024904. PMID:36353236. IF:5.200(Q1/3D).

Cediel, G, Teis, A, Codina, P, Julve, J, Domingo, M, Santiago-Vacas, E, Castelblanco, E, Amigo, N, Lupon, J, Mauricio, D, Alonso, N, Bayes-Genis, A. GlycA and GlycB as Inflammatory Markers in Chronic Heart Failure. AMERICAN JOURNAL OF CARDIOLOGY. 2022; 181DOI:10.1016/j.amjcard.2022.07.019. PMID:36008162. IF:2.800(Q3/6D).

Grinan, R, Escola-Gil, JC, Julve, J, Benitez, S, Rotllan, N. Epigenetic Regulation by microRNAs in Hyperhomocysteinemia-Accelerated Atherosclerosis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(20)DOI:10.3390/ijms232012452. PMID:36293305. IF:5.600(Q1/3D).

Gomez-Peralta, F, Carrasco-Sanchez, FJ, Perez, A, Escalada, J, Alvarez-Guisasola, F, Miranda-Fernandez-Santos, C, Mediavilla-Bravo, JJ, Gomez-Huelgas, R. Executive summary on the treatment of type 2 diabetes mellitus in elderly or frail individuals. 2022 update of the 2018 consensus document "Treatment of type 2 diabetes mellitus in the elderly". REVISTA CLINICA ESPANOLA. 2022; 222(8)DOI:10.1016/j.rce.2022.03.004. PMID:35753941. IF:2.900(Q2/5D).

Gimenez-Perez, G, Vlacho, B, Navas, E, Mata-Cases, M, Real, J, Cos, X, Franch-Nadal, J, Mauricio, D. Comorbid autoimmune diseases and burden of diabetes-related complications in patients with type 1 diabetes from a Mediterranean area. DIABETES RESEARCH AND CLINICAL PRACTICE. 2022; 191DOI:10.1016/j.diabres.2022.110031. PMID:35934173. IF:5.100(Q2/3D).

Harreiter, J, Mendoza, LC, Simmons, D, Desoye, G, Devlieger, R, Galjaard, S, Damm, P, Mathiesen, ER, Jensen, DM, Andersen, LLT, Dunne, F, Lapolla, A, Dalfra, MG, Bertolotto, A, Wender-Ozegowska, E, Zawiejska, A, Hill, D, Jelsma, JGM, Snoek, FJ, Worda, C, Bancher-Todesca, D, van Poppel, MNM, Corcoy, R, Kautzky-Willer, A. Vitamin D3 Supplementation in Overweight/Obese Pregnant Women: No Effects on the Maternal or Fetal Lipid Profile and Body Fat Distribution-A Secondary Analysis of the Multicentric, Randomized, Controlled Vitamin D and Lifestyle for Gestational Diabetes Prevention Trial (DALI). Nutrients. 2022; 14(18)DOI:10.3390/nu14183781. PMID:36145157. IF:5.900(Q1/2D).

Bermudez-Lopez, M, Marti-Antonio, M, Castro-Boque, E, Bretones, MD, Farras, C, Torres, G, Pamplona, R, Lecube, A, Mauricio, D, Valdivielso, JM, Fernandez, E. Development and Validation of a Personalized, Sex-Specific Prediction Algorithm of Severe Atheromatosis in Middle-Aged Asymptomatic Individuals: The ILERVAS Study. Frontiers in Cardiovascular Medicine. 2022; 9DOI:10.3389/fcvm.2022.895917. PMID:35928938. IF:3.600(Q2/5D).

Bahrami, J, Tomlinson, G, Murphy, HR, Feig, DS, Corcoy R., CHICO BALLESTEROS, ANA ISABEL, CONCEPTT Collaborative Grp. Impaired awareness of hypoglycaemia in women with type 1 diabetes in pregnancy: Hypoglycaemia fear, glycaemic and pregnancy outcomes. DIABETIC MEDICINE. 2022; 39(5)DOI:10.1111/dme.14789. PMID:35030277. IF:3.500(Q3/6D).

Zafaranieh, S, Dieberger, AM, Leopold-Posch, B, Huppertz, B, Granitzer, S, Hengstschlager, M, Gundacker, C, Desoye, G, van Poppel, MNM, Corcoy R., DALI Core Investigator Grp. Physical Activity and Sedentary Time in Pregnancy: An Exploratory Study on Oxidative Stress Markers in the Placenta of Women with Obesity. Biomedicines. 2022; 10(5)DOI:10.3390/biomedicines10051069. PMID:35625806. IF:4.700(Q1/3D).

Meek, CL, Oram, RA, McDonald, TJ, Feig, DS, Hattersley, AT, Murphy, HR, Corcoy R., CHICO BALLESTEROS, ANA ISABEL, CONCEPTT Collaborative Grp. Reappearance of C-Peptide During the Third Trimester in Type 1 Diabetes Pregnancy: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826-1834. DIABETES CARE. 2022; 45(2)DOI:10.2337/dci21-0054. PMID:35050370. IF:16.200(Q1/1D).

Franch-Nadal J., Granado-Casas M., Mata-Cases M., Ortega E., Vlacho B., Mauricio D.. Determinants of response to the glucagon-like peptide-1 receptor agonists in a type 2 diabetes population in the real-world. Primary Care Diabetes. 2022; 16(6)DOI:10.1016/j.pcd.2022.10.005. PMID:36336605. IF:2.900(Q2/5D).

Genua I., Franch-Nadal J., Navas E., Mata-Cases M., Giménez-Pérez G., Vlacho B., Mauricio D., Goday A.. Obesity and related comorbidities in a large population-based cohort of subjects with type 1 diabetes in Catalonia. Frontiers in Endocrinology. 2022; 13DOI:10.3389/fendo.2022.1015614. PMID:36531459. IF:5.200(Q1/3D).

Pérez-Montes de Oca A., Julián M.T., Pera G., Caballería L., Morillas R., Torán P., Expósito C., Franch-Nadal J., Mauricio D., Alonso N.. Dysglycemia in young women attenuates the protective effect against fatty liver disease. Frontiers in Endocrinology. 2022; 13DOI:10.3389/fendo.2022.971864. PMID:36479218. IF:5.200(Q1/3D).